BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3352837)

  • 1. Some immunological parameters in Hodgkin's disease.
    Dienstbier Z; Hermanská Z; Pĕnicka P; Zámecník J
    Neoplasma; 1988; 35(1):51-60. PubMed ID: 3352837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin-bearing lymphocytes in Hodgkin's disease.
    Koprivová H; Hermanská Z; Novák F; Blehová Z; Dienstbier Z
    Neoplasma; 1986; 33(1):63-9. PubMed ID: 3515213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
    J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
    González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
    Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
    Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
    Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
    Bockman RS
    J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP; Danilova NV
    Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitivity of Hodgkin's disease lymphocytes.
    Baral E; Blomgren H; Rotstein S
    J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.